Artiva Biotherapeutics, Inc.
ARTV
$11.78
$0.564.99%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -23.52M | -20.77M | -21.53M | -21.25M | -20.31M |
| Total Depreciation and Amortization | 666.00K | 666.00K | 662.00K | 641.00K | 628.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.39M | 1.30M | 1.27M | 1.04M | 1.33M |
| Change in Net Operating Assets | 506.00K | 4.08M | 391.00K | -3.41M | -1.49M |
| Cash from Operations | -20.95M | -14.73M | -19.20M | -22.98M | -19.84M |
| Capital Expenditure | -242.00K | -421.00K | -600.00K | -1.06M | -511.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.56M | 16.46M | 16.88M | 22.18M | 10.48M |
| Cash from Investing | 15.32M | 16.04M | 16.28M | 21.12M | 9.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -33.00K | -34.00K | -32.00K | -33.00K | -33.00K |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 0.00 | 138.00K |
| Repurchase of Common Stock | -210.00K | -87.00K | -104.00K | -39.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 131.00K | 0.00 | 99.00K | 0.00 | 134.00K |
| Cash from Financing | -112.00K | -121.00K | -37.00K | -72.00K | 239.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.75M | 1.19M | -2.96M | -1.93M | -9.63M |